The Business of Baby Factories: How Wealth and Science Mix
CRISPR and the Rise of the Designer Heir
Genetic engineering has moved from dystopian sci-fi to stark reality. In 2019, Chinese scientist He Jiankui shocked the world by editing human embryos using CRISPR, a breakthrough that sparked global outrage and legal crackdowns. But the genie was already out of the bottle.
Today, fertility clinics don’t just match sperm and egg—they rank embryos. Predictive algorithms assess IQ, health risks, and even behavioral tendencies. Want a future CEO? Pay to eliminate the competition before birth. This isn’t parenting. It’s shopping for traits, where only the "optimal" specimens are deemed worthy of life.
---
The Dehumanization of Existence: When Potential Outweighs Personhood
Surrogacy and gene editing reveal a chilling truth: children are no longer seen as gifts. They are products to be optimized.
This mirrors the bleakest dystopian tropes—societies where human worth is measured in genetic superiority, and only the "best" are granted a future. The irony? The same billionaires funding these technologies often bankroll the systemic inequalities that make exploitation possible.
---
The Final Question: What Happens When We Value Potential Over Personhood?
As embryo selection becomes mainstream and surrogacy evolves into a global trade, society stands at a crossroads. Will we embrace a future where human life is graded, ranked, and curated? Or will we reclaim the idea that every child—regardless of traits—deserves dignity, not just potential?
The answer will define more than just corporate legacies. It will define what it means to be human.
